Currently the Enterprise Value (EV) is not available for Arcutis Biotherapeutics.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 4.15,
with a Debt / Equity ratio of 0.7.
4.15
3.97
0.7
-1.01
-0.98
-4.73
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$574.68K
$-409.47K
342
0.56
1.32
Taxes
647K
-0.46%
Stock Price Statistics
The stock price has increased by 87.71% in the
last 52 weeks. The beta is 1.94, so Arcutis Biotherapeutics's
price volatility has been higher than the market average.
1.94
87.71%
15.93
14.54
58.43
1,664,742
Income Statement
In the last 12 months, Arcutis Biotherapeutics had revenue of 196.54M
and earned -140.04M
in profits. Earnings per share was -1.16.